pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,781 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: phase readout×type: grant×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings285
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06126172: Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions

    Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05310695: A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service. The NSAC Efficacy Study

    Sponsor: Nordlandssykehuset HF. Phase: NA. Conditions: Musculoskeletal Disorder, Anxiety Disorders, Depression, Fatigue, Pain, Occupational Exposure, Work Related Stress, Workplace Bullying, Employment, Sickness Absence, Return to Work

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07429695: Eye-Tracking Interactive Agent in Non-verbal ICU Patients

    Sponsor: Shanghai Zhongshan Hospital. Phase: NA. Conditions: Eye Tracking, ICU, Communication Barriers, Non-Verbal Communication

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07102095: A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose

    Sponsor: Bayer. Phase: PHASE1. Conditions: Hepatic Insufficiency, Liver Diseases, Pharmacokinetics, Drug Metabolism

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07442877: A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

    Sponsor: Haisco Pharmaceutical Group Co., Ltd.. Phase: PHASE2. Conditions: Postoperative Pain Management

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT05973877: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07355075: A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

    Sponsor: Turn Therapeutics. Phase: PHASE2. Conditions: Eczema Atopic Dermatitis, Eczema, Atopic Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07491757: Determining the Effects of Training on Nursing Students Using Two Different Methods for Maintaining Fluid and Electrolyte Balance in a Child Trapped Under a Collapse

    Sponsor: Selcuk University. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07390357: Effect of Photobiomodulation on Orthodontic Tooth Movement

    Sponsor: Wroclaw Medical University. Phase: NA. Conditions: Class II Malocclusion, Orthodontic Tooth Movement

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06359301: H-34 DELTA Revision Cup

    Sponsor: Limacorporate S.p.a. Phase: . Conditions: Hip, Osteoarthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07681401: Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood

    Sponsor: University of Utah. Phase: NA. Conditions: Family Caregivers, Dementia, Financial Wellbeing, Financial Coaching

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05575401: Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy

    Sponsor: Loma Linda University. Phase: NA. Conditions: Sleep-Disordered Breathing, Sleep Apnea Syndromes in Children, Sleep Apnea, Obstructive, Tonsillitis, Tonsillar Hypertrophy, Tonsil Stone, Tonsil Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05423301: Global Physiotherapy in ICU Patients With High Risk Extubation Failure

    Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Acute Respiratory Failure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07218601: Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06166901: Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)

    Sponsor: Alcon Research. Phase: NA. Conditions: Aphakia, Astigmatism, Presbyopia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07310212: Evaluation of Postoperative Pain and Success Rate Between Lateral Condensation and Warm Vertical Obturation Techniques

    Sponsor: University of Jordan. Phase: NA. Conditions: Necrotic Pulp, Asymptomatic Apical Periodontitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04069312: Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)

    Sponsor: Johns Hopkins University. Phase: PHASE4. Conditions: Chronic Obstructive Pulmonary Disease Severe, Chronic Bronchitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07185919: A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

    Sponsor: Ipsen. Phase: . Conditions: Progressive Familial Intrahepatic Cholestasis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06528665: Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects

    Sponsor: Corium Innovations, Inc.. Phase: . Conditions: Multiple Sclerosis, Ulcerative Colitis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07545265: SKB565 for Injection in Advanced Solid Tumors

    Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04506567: Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC

    Sponsor: Weill Medical College of Cornell University. Phase: PHASE1. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05259527: Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy

    Sponsor: Virginia Commonwealth University. Phase: PHASE2. Conditions: Neuropathic Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03495427: PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: PHASE2. Conditions: Prostate Cancer, Recurrent Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06043427: Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma

    Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Gastroesophageal Adenocarcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05541627: A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease

    Sponsor: AskBio France, SAS, a subsidiary of AskBio Inc.. Phase: PHASE1. Conditions: Huntington Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05866861: A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus

    Sponsor: Cugene Inc.. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus, SLE (Systemic Lupus), Autoimmune

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04899661: A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia

    Sponsor: Bayer. Phase: . Conditions: Renal Anemia

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07272161: Pilot Evaluation of the StarGuide Next Generation SPECT/CT System

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Nuclear Medicine

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07613970: Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation

    Sponsor: Vrije Universiteit Brussel. Phase: PHASE1. Conditions: Stroke, Cerebrovascular Accident (CVA), Ischemia Stroke, Hemorrhage Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06437470: Effect of Blood Flow Restriction Technique After Anterior Cruciate Ligament Reconstruction

    Sponsor: Cairo University. Phase: NA. Conditions: Anterior Cruciate Ligament Injuries

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05462873: A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03391973: Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)

    Sponsor: AHS Cancer Control Alberta. Phase: PHASE2. Conditions: Carcinoma of Unknown Primary

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07646873: PET-Enabled Dual-Energy CT in Multiple Myeloma

    Sponsor: University of California, Davis. Phase: NA. Conditions: Multiple Myeloma (MM)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02567669: Muscle Loss and Fatigue as a Consequence of Radiotherapy

    Sponsor: Essentia Health. Phase: . Conditions: Breast Cancer, Fatigue, Sarcopenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04264741: Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse

    Sponsor: Shanghai Mental Health Center. Phase: NA. Conditions: Methamphetamine Abuse

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06052254: Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

    Sponsor: Teikoku Pharma USA, Inc.. Phase: PHASE2. Conditions: Agitation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05695105: Novel Treatment for Dental Ankylosis

    Sponsor: Rutgers, The State University of New Jersey. Phase: NA. Conditions: Dental Ankylosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07604805: Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension

    Sponsor: Guangdong Provincial People's Hospital. Phase: NA. Conditions: Idiopathic Pulmonary Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07404956: THE EFFECT OF SURGICAL MASK AND N95 MASK USE ON SURGICAL SMOKE IN OPERATING ROOM NURSES

    Sponsor: Bartın Unıversity. Phase: NA. Conditions: Surgical Smoke Exposure, Occupational Exposure to Surgical Smoke, Headache, Dizziness, Nause and Vomiting, Fatigue Symptom, Eye Allergies, Abdominal Pain (AP), Heart Rate Determination, SpO2, Muscle Weakness | Patient, Muscle Aches, Dispnea

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06722729: A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

    Sponsor: Kissei Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05565131: Performance Measurement and Safety Evaluation of the PYTHEAS® ODYSSEE Angular Assistance System for Intra-pedicular Screw Placement in Adult Spine Surgery

    Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: NA. Conditions: Pedicle Screw, Surgical Navigation Systems

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05252702: Aveir DR i2i Study

    Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Cardiac Pacemaker, Artificial, Cardiac Rhythm Disorder, Bradycardia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06417853: Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)

    Sponsor: Vaxxas Pty Ltd. Phase: PHASE1. Conditions: H7N9 Influenza

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06877468: Toddler Tastes Study

    Sponsor: State University of New York at Buffalo. Phase: NA. Conditions: Dietary Behavior

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03935750: STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon

    Sponsor: University of Pittsburgh. Phase: NA. Conditions: Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Reconstruction, Joint Instability

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07244991: Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics

    Sponsor: Cardenal Herrera University. Phase: NA. Conditions: Dental Caries, Streptococcus Mutans, Tooth Demineralization, Orthodontic Appliances, Fixed

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07597174: Mobile App vs. In-Person Pelvic Floor Rehabilitation for Urinary Leakage in Adult Women

    Sponsor: Unidade Local de Saúde São João. Phase: NA. Conditions: Urinary Incontinence , Stress

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07607574: Factors of Potentially Dangerous Drug Interactions in Patients With Cardiovascular Diseases and Multimorbidity

    Sponsor: National Medical Research Center for Therapy and Preventive Medicine. Phase: . Conditions: Cardiovascular Diseases, Multimorbidity, Drug Interactions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07425418: Italian Validation of a Pressure Injury Risk Assessment Scale (Braden QDS) in the Neonatal Intensive Care Unit

    Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Pressure Ulcers in the Neonatal Population

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06598410: Playing Digital Games and Watching Cartoons on Children&Amp;#39;s Pain, Fear, and Anxiety

    Sponsor: Tarsus University. Phase: NA. Conditions: Pain, Fear, Anxiety, Children, Emergency

    full page →ctgov ↗
    ← prev
    page 71 of 96
    next →